New SwiftArrayStudio analyzer and updated genotyping arrays deliver results in as little as 30 hours, enabling researchers to drive impactful, scalable genetic researchWALTHAM, Mass.--(BUSINESS WIRE)- ...
About Vaxxas Vaxxas is a biotechnology company pioneering a needle-free vaccination technology designed to enhance immune response, reduce costs, and improve accessibility. The company recently ...
9don MSN
Dozens of blind people can see thanks to revolutionary new microchip: ‘Never been done before’
"Before receiving the implant, it was like having two black discs in my eyes, with the outside distorted," said Sheila Irvine ...
Geographic atrophy due to age-related macular degeneration (AMD) is the leading cause of irreversible blindness and affects more than 5 million persons worldwide. No therapies to restore vision in ...
Geographic atrophy, an advanced form of dry age-related macular degeneration, leaves almost five million people around the ...
AI translates electrical signals to the brain to help restore reading vision to treat a common form of blindness that was ...
A wireless microchip implanted beneath the retina improved vision in 81% of patients with advanced age-related macular ...
Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that results from a sex-specific analysis of 160 real-world ...
Surmodics Announces PROWL Registry Sex-Specific Data to be Presented at TCT Conference on October 28
Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that Dr. Peter Monteleone will present data from a sex-specific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback